lung cancer Flashcards

1
Q

are all lung cancer patients smokers?

A

no. 10-15 % of smokers have never smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where is cancer in rank of types of cancer death causes?

A

its the first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

risk factors of lung cancer (age, sex and 2 others?

A

age - peak 75-90
sex M>F
lower socioeconomic status
smoking (biggest single factor- duration, intensity, when stopped)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

causes other than smoking

A

Passive smoking (~15% of never smokers)
Asbestos – exposure (plumbers, ship-builders, carriage workers, carpenters, etc) – risk up to x2
Radon – e.g. silver miners in Germany late 19th century; 1950s uranium mining in Colorado
Indoor cooking fumes – wood smoke, frying fats
Chronic lung diseases (COPD, fibrosis)
Air pollution
Familial/ genetic – several loci identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what cells can lung cancer arise form?

A

ALL differentiated and undifferentiated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the pathogenesis of lung cancer: (how does it arise in a cell)

A

1) interaction between inhaled carcinogens and the epithelium of upper AND lower airways

2) formation of DNA adducts: DNA pieces covalently bound to a cancer-causing chemical
(note: specifically oncogenes- tumour suppressor genes- key to pathogenesis of lung canc)

3) persisting DNA adducts/ misplaced lead to mutation causing

4) GENOMIC ALTERATIONS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what factor distinguishes different types of lung cancer diseases?

A

cell type form which cancer originates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 broadest categories of lung cancer diseases and which is more aggressive

A

Non small cell lung cancer (includes: squamous cell carcinoma, adenocarcinoma, large cell lung cancer)
and
small cell lung cancer (more serious / dangerous/ highly malignant )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the positive thing about small cell lung cancer?

A

responds well to chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what cells does small cell lung cancer originate from

A

pulmonary neuroendocrine cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what cells does large cell lung cancer originate form

A

heterogenous group of cells that are undifferentiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cell origin of adenocarcinoma and location in pulmonary system

A

mucus producing glandular tissue - more peripherally located

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

squamous cell carcinoma : what part of pulm epithelium does it arise form? location in resp system ?

A

bronchial epithelium, centrally located

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

prevalence of each type of cancer cell diseases and how has this recently changed

A

40% adenocarcinoma most prevalent from 1980s onwards due to low tar cigarettes, inhaled more deeply / retained longer

30% squamus cell carcinoma (used to be most prevalent)

large cell lung cancer 15% = small cell lung cancer 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why do we care to know the relevant oncogenes?

A

for directed treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is tyrosine kinase?

A

enzyme that regulates growth, proliferation and differenciation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are some important oncogenes in non smokers

A

epidermal growth factor RECEPTOR (EGFR) tyrosine kinase
(women, asian)

anaplastic lymphoma KINASE (ALK) tyrosine kinase
(younger)

c-ROS oncogene 1 (ROS1) RECEPTOR to tyrosine kinase
(Younger)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

oncogene for smokers

A

BRAF (downstream cell- cycle signalling mediator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what type of lung cancer is each oncogene associated with

A

EGFR: 15-30% of adenocarcinomas

the rest are

2-7% ALK
1-2% c-ROS
1-3% BRAF
:non small lung caners

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

KEY SYMPOTMS OF LUNG CANCER

A

weight loss
cough
breathless
fatigue
chest pain
haemoptysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

common or uncommon to have asymptomatic lung canc?

A

common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

features of advanced metastatic disease (3 categories and specifics) (features: diseases in the body)

A

1) neurological features a) focal weakness, b) seizures c) spinal cord compression

2) bone pain

3) paraneoplastic syndromes
a) clubbing (fingers thing) b) hypercalaemia c) hyponatraemia d) cushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

signs of lung cancer

A

cachexia: (loss of muscle and fat- skeleton looking)

horners syndrome : one eyelid dropped: (happens bc lung cancer compresses sympathetic nerve going up)

clubbing: fingers tips big and weird nails

pemberton’s sign (superior vena cava obstruction - red face when raise hans)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

diagnostic strategy of lung cancer

A

1) establish mokst likely diagnosis

2) establish fitness for investigation and treatment

3) confirm diagnosis and histological type (alse genomic test it consideringn systemic treatment in nsclc- all these tests also gelp tetermine treatment)

4) confirm staging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what has changed in terms of lung cancer screening?

A

people at high risk (basically smokers 55-74- age group younger than actual peak of disease prevalence bc balance tryna be found with quality of life- more life for younger) invited for screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what scan do you see lung cancer?

A

x ray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what scan do you stage lung cancer and what specific area?

A

ct- chest and abdomen

28
Q

when is PET- ct used and why is it appropriate for that use

A

to exclude occult (hidden) metastases ex in lymph nodes ect ]

Metabolic scans, patients get fdg, glucose, glucose goes to areas of high metabolic activity – higher uptske of gluc light up – so tumours light up

29
Q

what determines what type of biopsy you do?

A

accessibility, availability and impact on staging

30
Q

what are the 3 types of biopsy and when do you do each?

A

bronchoscopy using a fibrotic ENDOSCOPE - useful for tumours of central and segmental airways (also useful to visualise tumour before surgery)

stage mediastinum +/- achieve tissue diagnosis

CT guided lung biopsy - to access peripheral lung tumours

31
Q

3 components/ scales of IASLC (International Association for the Study of Lung Cancer) 8th edition lung cancer staging system

A

TNM

T1-4: size and location
N: 0-3: lymph node involvement mediastinum and beyond
M0-1c: metastases + number (= M1a, 1b, 1c)

32
Q

what is M0, M1A, M1B, M1C?

A

m0: No distant metastases
m1a: malignant pleural pericardial effusion or nodules
m1b: single extrathoracic metastasis
m1c: multiple extrathoracic metastasis

33
Q

what are N0, N1, N2, N3

A

0: no regional node metastasis
n1: ipsilateral pulmonary or hilar nodes
n2: ipsilateral mediastinal/ subcranial nodes
n3: contralateral mediastinal/ hilar or supraclavicular nodes

34
Q

what is t1 t2 t3 t4

A

t1: </= 3 cm

t2 is either: 5 >/= t2: > 3
OR involves visceral pleura / main bronchus

t3: either 7>/=tumor >5
OR invading chest wall, pericardium, phrenic nerve
OR if theres separate tumor nodule in same lobe

t4: >7 cm
OR invading MEDIASTINUM, diaphragm, heart, great vessels, reccurent larengeal nerve, carina, trachea, oesophagus, spine

35
Q

what are the T1a T1b T1C and T2a T2b

A

is you remember the large range, they are the splits of each cm so

t1a</= 1
1<b</=2
c: 2-3(=)

t2a 3-4(=)
t2b 4-5(=)

36
Q

what dimension of the tumour counts or tumour size?

A

the biggest dimension

37
Q

check slife 22 with images

A
38
Q

detemrinants of treatment

A

disease related:
cancer stage, histology

patient related:
patient fitness, patient preference

resource related:
health service factors

39
Q

0-5 scale of patient fitnes based on who - perofrmance status

A

0: asymptomatic, completely capable of pre-disease activities

1: symptomatic but completely ambulatory, only thing they cant do is strenus exercise

2: sumpotmatic but more than 50% of the time mobile, can do all self care but not some extra work

3: sympotmatic more than 50% chair or bed bound, difficulty in self care

4: totally disabled and completely confined to bed or chair

5: death

40
Q

is surgery resection standard care approach for any stage in disease?

A

yes, for early stage

41
Q

what is the usual parts rmeoved in surgery of early stage?

A

lymphadenectomy and lobectomy or sublobar resection if stage 1

42
Q

what is an alternative that patients can choose other than surgery for early disease? when is it particularly prefered? explain that method a bit

A

radical radiotherapy - stereotactic (σκέψου τον κρατάμε στερεό και ατακ) ablative body radiotherapy

when there are comorbidities

high percision targeting with multiple convergent beams (v high radioactive dose)

43
Q

why is surgery still more effective than radical radiotherapy?

A

because you also remove lymph nodes whereas in radiotherapy u dont adress lymph nodes that may have microcancer

44
Q

what are the types of systemic treatment?

A

immunotherapy, oncogene directed treatment, cytotoxic chemotherapy

45
Q

when are oncogene directed treatments given?

A

when there is
1) no SCLC
2) theres metastasis
3) theres mutation

46
Q

when do you give immunotherapy?

A

when there is
1) NO SCLC
2) theres metastasis
3) no mutation
4) PDL1>/= 50% (you stain for this)

47
Q

when do you give cytotoxic chemotherapy?

A

same criteria as immunotherapy and you give it along with immunotherapy

48
Q

NICE approved medications for EGFR mutation?

A

erlotinib, gefitinib, afatinib, dacomitinib, and osimertinib

49
Q

ALK approved meds

A

ALK: crizotinib, ceritinib, alectinib, brigatinib, lorlatinib

50
Q

ros-1 targeted meds

A

ROS-1: crizotinib, entrectinib

51
Q

What is the effect of oncogene targeted treatment compared to chemotherapy in terms of progression free survival and overall survival?

A

oncogene targeted therapy is more effective in terms of progression free survival but less in overall survival (trials for erlotinib and crizotinib showed same trend)

52
Q

side effects of oncogene targeted therapy

A

rash, diarrhoea and uncommonly pneumonitis

generally tablet is well tolerated though

53
Q

NICE approved immunotherapy drugs

A

Pembrolizumab, atezolizumab, nivolumab

53
Q

efficacy compared to chemotherapy ?

A

better progression free survival AND overall survival

54
Q

side effects of immunotherapy

A

generally well tolerated
immune related side effects in 10-15 % 9THYROID, SKIN, BOWEL, lung, liver)

55
Q

what is the mechanism of immunotherapy?

A
  • theres the PD-L1 receptor in tumour cells that binds PD-1 on T cells and inhibits t cell from killing tumor cell
  • treatment is anti-PD-1 and anti PD-L1 so antibodies bind on both sides of this interaction and the t cell is now allowed to kill the tumour cell
56
Q

what chemical element are cytotoxic chemotherapies all based on? give drug examples

A

platinium- based regiments
eg carboplatin, cisplatin, paclitaxel, pemetrexed

57
Q

which immunotherpay drug have there been trials about/ evidence

A

pembrolizumab

58
Q

efficacy of chemotherapy

A

when sued alone MODEST imporvements in ONE YEAR survival compared to best SUPPORTIVE CARE

however much worse than pembrolizumab which has 23% surv rate for 2 yrs vs 5% chemo

59
Q

side effects of chemo

A

fatigue
nausea
bone marrow supression
nephrotoxicity

quality of life poorly rate din trials…

60
Q

palliative supportive care when is it given and what it involves?

A

Should be offered as standard to all patients with advanced stage disease
Symptom control, psychological support, education, practical and financial support, planning for end of life

61
Q

key group of specialists in palliative care

A

lung cancer nurses

62
Q

efficacy of palliative care?

A

1) survuval rates improved
2) quality of life imporved (less depression
3)

63
Q

what is the difference between chemo given in early stage disease vs locally advanced?

A

first is curative intent instead of surgery, second is ADJUVANT, meaning given along with surgery (after)

64
Q

what is another treatment plan for locally adv dis other than surg and chemo

A

radiotherapy and chemotherapy and maybe also immuno

65
Q

categories of metastatic disease based on treatment

A

with targetable mutation (tyrosine kinase inhibitor)

no mutations and PDL-1 positive or negative

palliative care alone or with the above (patient wishes)